2. Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease–implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol 2013;62:1–10.
3.
3. Zivelonghi C, Pesarini G, Scarsini R, et al. Coronary catheterization and percutaneous in- terventions after transcatheter aortic valve im- plantation. Am J Cardiol 2017;120:625–31.
4. Blumenstein J, Kim WK, Liebetrau C, et al. Challenges of coronary angiography and inter- vention in patients previously treated by TAVI. Clin Res Cardiol 2015;104:632–9.
5.
5. Htun WW, Grines C, Schreiber T. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve. Catheter Cardiovasc Interv 2017 Oct 8.
6. Allali A, El-Mawardy M, Schwarz B, et al. Incidence, feasibility and outcome of percuta- neous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience. Cardiovasc Revasc Med 2016;17:391–8.
7.
7. Yudi MB, Sharma SK, Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2018 Mar 27;71(12):1360-1378.
8. Reardon MJ, Van Mieghem NM, Popma JJ, et al., SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017; 376:1321–31.
Tác giả
Phan Tuấn Đạt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Yeo Khung Keong: Trung tâm Tim mạch Quốc gia Singapore;
Phạm Mạnh Hùng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;